Home › Trial NCT01191060
Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years
- Trial IDNCT01191060
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorUniversity Hospital, Toulouse
- Enrollment700
- Start date2010-10
- ConditionsMyeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.